Bruce G. Haffty, MD, is RSNA president-elect for 2021. Dr. Haffty is associate vice chancellor, Cancer Programs, at Rutgers Biomedical and Health Sciences. He also serves as professor and chairman in the Department of Radiation Oncology at Rutgers Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School.
Haffty
As president-elect, Dr. Haffty will work to maintain strong governance of the Society and raise the profile of RSNA and radiology outside of the radiology community.
“The RSNA Board of Directors has held a number of valuable and extensive discussions concerning the governance of our organization,” Dr. Haffty said. “I look forward to continuing those discussions and determining the optimal governance structure moving forward for RSNA. In addition, the Board plans to explore collaborations with other organizations that will be beneficial for our Society and our specialty.”
Dr. Haffty’s extensive service to RSNA includes serving as third vice president and as co-chair of the Bolstering Oncoradiologic and Oncoradiotherapeutic Skills for Tomorrow (BOOST) Program. At RSNA 2009, he delivered the Annual Oration in Radiation Oncology. Dr. Haffty was named RSNA Outstanding Educator in 2013. Dr. Haffty has been on the RSNA Board of Directors since 2014, serving as liaison for science and chair. He also served on the RSNA News editorial board.
Dr. Haffty completed his medical school and residency training at Yale University School of Medicine and spent the next 18 years specializing in breast, head and neck cancers in Yale’s Department of Therapeutic Radiology. He served on the faculty at Yale from 1988 through 2005. Dr. Haffty was promoted to professor of therapeutic radiology, served as residency program director from 1992 through 2004, and vice chairman and clinical director from 2002 to 2005.
Dr. Haffty’s research on new methods of delivering radiation therapy for breast cancer has focused on molecular and genetic factors as they relate to radiation resistance and outcomes in patients. Dr. Haffty is a leader in national clinical trials and is currently co-investigator on several national clinical trials through the NRG Oncology and Alliance for Clinical Trials in Oncology cooperative groups.
At Rutgers Robert Wood Johnson Medical School, New Jersey Medical School and Cancer Institute of New Jersey — now part of Rutgers, Dr. Haffty spearheaded the expansion of the Radiation Oncology Program and developed residency programs in radiation oncology and medical physics — the only such programs in the state of New Jersey.
Dr. Haffty has authored or co-authored 50 books, book chapters and theses, more than 400 peer-reviewed articles and numerous editorials and letters. In addition to editing the comprehensive Handbook of Radiation Oncology, Dr. Haffty has served on numerous editorial boards. He currently serves on the editorial board of The Breast Journal and serves as deputy editor of Journal of Clinical Oncology.
Through his extensive work with the American Society for Radiation Oncology, Dr. Haffty served as the founding president of the Association of Directors of Radiation Oncology Programs in 2000. Dr. Haffty is a past president of the American Radium Society, past chairman of the Residency Review Committee in Radiation Oncology, past president of the American Board of Radiology and past president of American Society for Radiation Oncology.
